S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.32 (+0.09%)
AAPL   146.96 (+0.09%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,845.99 (+0.77%)
TSLA   774.81 (+2.81%)
AMZN   3,425.03 (+0.26%)
NVDA   220.70 (-1.83%)
BABA   145.05 (-4.06%)
NIO   35.37 (-1.78%)
CGC   13.90 (-4.53%)
GE   103.81 (+0.83%)
MU   74.02 (-0.03%)
AMD   105.82 (-0.31%)
T   27.12 (-0.26%)
F   13.76 (+0.36%)
ACB   5.96 (-3.09%)
DIS   176.04 (-0.12%)
PFE   43.97 (-0.50%)
BA   221.41 (+0.14%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.32 (+0.09%)
AAPL   146.96 (+0.09%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,845.99 (+0.77%)
TSLA   774.81 (+2.81%)
AMZN   3,425.03 (+0.26%)
NVDA   220.70 (-1.83%)
BABA   145.05 (-4.06%)
NIO   35.37 (-1.78%)
CGC   13.90 (-4.53%)
GE   103.81 (+0.83%)
MU   74.02 (-0.03%)
AMD   105.82 (-0.31%)
T   27.12 (-0.26%)
F   13.76 (+0.36%)
ACB   5.96 (-3.09%)
DIS   176.04 (-0.12%)
PFE   43.97 (-0.50%)
BA   221.41 (+0.14%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.32 (+0.09%)
AAPL   146.96 (+0.09%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,845.99 (+0.77%)
TSLA   774.81 (+2.81%)
AMZN   3,425.03 (+0.26%)
NVDA   220.70 (-1.83%)
BABA   145.05 (-4.06%)
NIO   35.37 (-1.78%)
CGC   13.90 (-4.53%)
GE   103.81 (+0.83%)
MU   74.02 (-0.03%)
AMD   105.82 (-0.31%)
T   27.12 (-0.26%)
F   13.76 (+0.36%)
ACB   5.96 (-3.09%)
DIS   176.04 (-0.12%)
PFE   43.97 (-0.50%)
BA   221.41 (+0.14%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.32 (+0.09%)
AAPL   146.96 (+0.09%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,845.99 (+0.77%)
TSLA   774.81 (+2.81%)
AMZN   3,425.03 (+0.26%)
NVDA   220.70 (-1.83%)
BABA   145.05 (-4.06%)
NIO   35.37 (-1.78%)
CGC   13.90 (-4.53%)
GE   103.81 (+0.83%)
MU   74.02 (-0.03%)
AMD   105.82 (-0.31%)
T   27.12 (-0.26%)
F   13.76 (+0.36%)
ACB   5.96 (-3.09%)
DIS   176.04 (-0.12%)
PFE   43.97 (-0.50%)
BA   221.41 (+0.14%)
BAC   42.14 (+1.08%)
NYSE:BCSF

Bain Capital Specialty Finance Stock Forecast, Price & News

$15.16
-0.02 (-0.13 %)
(As of 09/24/2021 03:59 PM ET)
Add
Compare
Today's Range
$15.14
$15.23
50-Day Range
$14.66
$15.50
52-Week Range
$8.92
$16.45
Volume1,850 shs
Average Volume197,958 shs
Market Capitalization$978.76 million
P/E Ratio5.92
Dividend Yield9.04%
Beta1.63
30 days | 90 days | 365 days | Advanced Chart
Receive BCSF News and Ratings via Email

Sign-up to receive the latest news and ratings for Bain Capital Specialty Finance and its competitors with MarketBeat's FREE daily newsletter.


Bain Capital Specialty Finance logo

About Bain Capital Specialty Finance

Bain Capital Specialty Finance, Inc. operates as a development stage company, which intends to focus on senior investments with a first or second lien on collateral and strong structures and documentation, intended to protect the lender. The company was founded on October 5, 2015 and is headquartered in Boston, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.02 out of 5 stars

Finance Sector

641st out of 1,331 stocks

Holding & Other Investment Offices Industry

12th out of 481 stocks

Analyst Opinion: 1.0Community Rank: 3.5Dividend Strength: 1.7Insider Behavior: 0.8Valuation: 3.1 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Bain Capital Specialty Finance (NYSE:BCSF) Frequently Asked Questions

Is Bain Capital Specialty Finance a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Bain Capital Specialty Finance stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BCSF, but not buy additional shares or sell existing shares.
View analyst ratings for Bain Capital Specialty Finance
or view top-rated stocks.

What stocks does MarketBeat like better than Bain Capital Specialty Finance?

Wall Street analysts have given Bain Capital Specialty Finance a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bain Capital Specialty Finance wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Bain Capital Specialty Finance's next earnings date?

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Bain Capital Specialty Finance
.

How were Bain Capital Specialty Finance's earnings last quarter?

Bain Capital Specialty Finance, Inc. (NYSE:BCSF) posted its earnings results on Tuesday, August, 3rd. The company reported $0.34 earnings per share for the quarter, meeting analysts' consensus estimates of $0.34. The company earned $46.49 million during the quarter, compared to analysts' expectations of $46.01 million. Bain Capital Specialty Finance had a net margin of 86.26% and a trailing twelve-month return on equity of 8.14%.
View Bain Capital Specialty Finance's earnings history
.

How has Bain Capital Specialty Finance's stock price been impacted by Coronavirus (COVID-19)?

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BCSF shares have decreased by 10.0% and is now trading at $15.16.
View which stocks have been most impacted by COVID-19
.

How often does Bain Capital Specialty Finance pay dividends? What is the dividend yield for Bain Capital Specialty Finance?

Bain Capital Specialty Finance declared a quarterly dividend on Wednesday, August 4th. Stockholders of record on Thursday, September 30th will be given a dividend of $0.34 per share on Friday, October 29th. This represents a $1.36 dividend on an annualized basis and a yield of 8.97%. The ex-dividend date of this dividend is Wednesday, September 29th.
View Bain Capital Specialty Finance's dividend history
.

Is Bain Capital Specialty Finance a good dividend stock?

Bain Capital Specialty Finance pays an annual dividend of $1.36 per share and currently has a dividend yield of 9.04%. BCSF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Bain Capital Specialty Finance does not yet have a strong track record of dividend growth. The dividend payout ratio of Bain Capital Specialty Finance is 93.15%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Bain Capital Specialty Finance will have a dividend payout ratio of 99.27% in the coming year. This indicates that Bain Capital Specialty Finance may not be able to sustain their current dividend.
View Bain Capital Specialty Finance's dividend history.

What price target have analysts set for BCSF?

2 analysts have issued 12 month price targets for Bain Capital Specialty Finance's stock. Their forecasts range from $14.00 to $16.00. On average, they expect Bain Capital Specialty Finance's stock price to reach $15.00 in the next year. This suggests that the stock has a possible downside of 1.1%.
View analysts' price targets for Bain Capital Specialty Finance
or view top-rated stocks among Wall Street analysts.

Who are Bain Capital Specialty Finance's key executives?

Bain Capital Specialty Finance's management team includes the following people:
  • Michael A. Ewald, Chief Executive Officer & Director
  • Michael Boyle, President
  • Sally F. Dornaus, Chief Financial Officer
  • James Goldman, Chief Compliance Officer
  • Michael Bennett Treisman, Secretary & Vice President

What other stocks do shareholders of Bain Capital Specialty Finance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), AbbVie (ABBV), The Walt Disney (DIS), Square (SQ), AT&T (T), Bristol-Myers Squibb (BMY), The Home Depot (HD), Advanced Micro Devices (AMD), Bank of America (BAC) and Energy Transfer (ET).

When did Bain Capital Specialty Finance IPO?

(BCSF) raised $156 million in an initial public offering on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

What is Bain Capital Specialty Finance's stock symbol?

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Who are Bain Capital Specialty Finance's major shareholders?

Bain Capital Specialty Finance's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Employees Retirement System of Texas (3.25%), Bank of America Corp DE (2.46%), Invesco Ltd. (1.56%), Starr International Co. Inc. (1.22%), Van ECK Associates Corp (1.20%) and Morgan Stanley (0.86%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Sally F Dornaus and Thomas A Hough.
View institutional ownership trends for Bain Capital Specialty Finance
.

Which institutional investors are selling Bain Capital Specialty Finance stock?

BCSF stock was sold by a variety of institutional investors in the last quarter, including Employees Retirement System of Texas, Rivernorth Capital Management LLC, Sumitomo Mitsui Trust Holdings Inc., Muzinich & Co. Inc., HighTower Advisors LLC, California Public Employees Retirement System, Millennium Management LLC, and Schonfeld Strategic Advisors LLC.
View insider buying and selling activity for Bain Capital Specialty Finance
or view top insider-selling stocks.

Which institutional investors are buying Bain Capital Specialty Finance stock?

BCSF stock was acquired by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Ares Management LLC, Morgan Stanley, Morgan Stanley, Sierra Capital LLC, Invesco Ltd., Centaurus Financial Inc., and Mackenzie Financial Corp. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Sally F Dornaus, and Thomas A Hough.
View insider buying and selling activity for Bain Capital Specialty Finance
or or view top insider-buying stocks.

How do I buy shares of Bain Capital Specialty Finance?

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bain Capital Specialty Finance's stock price today?

One share of BCSF stock can currently be purchased for approximately $15.16.

How much money does Bain Capital Specialty Finance make?

Bain Capital Specialty Finance has a market capitalization of $978.76 million and generates $194.46 million in revenue each year. The company earns $8.28 million in net income (profit) each year or $1.46 on an earnings per share basis.

What is Bain Capital Specialty Finance's official website?

The official website for Bain Capital Specialty Finance is www.baincapital.com.

Where are Bain Capital Specialty Finance's headquarters?

Bain Capital Specialty Finance is headquartered at 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116.

How can I contact Bain Capital Specialty Finance?

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at (617) 516-2000 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.